Literature DB >> 8957537

Regulation of myocardial calcium channels by cyclic AMP metabolism.

L Hove-Madsen1, P F Méry, J Jurevicius, A V Skeberdis, R Fischmeister.   

Abstract

Hormonal regulation of cardiac inotropism is often correlated with modification of the L-type Ca-channel current. Among several regulatory pathways that control Ca-channel activity, the best described one is the cAMP cascade. Cyclic AMP-dependent phosphorylation of the Ca-channel results in an increase of the mean open probability of the individual Ca-channels and, thus, of the macroscopic Ca current. Modulation of cAMP concentration can take place at the level of adenylyl cyclases or cAMP phosphodiesterases. Of major interest is the fact that the activity of two different forms of phosphodiesterases is controlled by the level of intracellular cGMP. Thus, cAMP metabolism is intimately associated with cGMP metabolism, and both determine the degree of cAMP-dependent phosphorylation of cardiac Ca-channels. This brief discussion will focus on these two levels of control and their relative importance in the cAMP-dependent regulation of myocardial Ca-channels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957537     DOI: 10.1007/bf00795355

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  84 in total

1.  Effects of atrionatriuretic factor on Ca2+ current and Cai-independent transient outward K+ current in human atrial cells.

Authors:  B Le Grand; E Deroubaix; J P Couétil; E Coraboeuf
Journal:  Pflugers Arch       Date:  1992-08       Impact factor: 3.657

Review 2.  Direct regulation of cardiac Ca2+ channels by G proteins: neither proven nor necessary?

Authors:  H C Hartzell; R Fischmeister
Journal:  Trends Pharmacol Sci       Date:  1992-10       Impact factor: 14.819

3.  Factors released from endocardium of the ferret and pig modulate myocardial contraction.

Authors:  J A Smith; A M Shah; M J Lewis
Journal:  J Physiol       Date:  1991-08       Impact factor: 5.182

4.  Nitric oxide synthase does not participate in negative inotropic effect of acetylcholine in frog heart.

Authors:  P F Méry; L Hove-Madsen; J M Chesnais; H C Hartzell; R Fischmeister
Journal:  Am J Physiol       Date:  1996-04

5.  Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes.

Authors:  R P Xiao; X Ji; E G Lakatta
Journal:  Mol Pharmacol       Date:  1995-02       Impact factor: 4.436

6.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

7.  Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase.

Authors:  P F Méry; V Brechler; C Pavoine; F Pecker; R Fischmeister
Journal:  Nature       Date:  1990-05-10       Impact factor: 49.962

8.  Inhibition by glucagon of the cGMP-inhibited low-Km cAMP phosphodiesterase in heart is mediated by a pertussis toxin-sensitive G-protein.

Authors:  V Brechler; C Pavoine; R Hanf; E Garbarz; R Fischmeister; F Pecker
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

9.  Acetylcholine elicits a rebound stimulation of Ca2+ current mediated by pertussis toxin-sensitive G protein and cAMP-dependent protein kinase A in atrial myocytes.

Authors:  Y G Wang; S L Lipsius
Journal:  Circ Res       Date:  1995-04       Impact factor: 17.367

10.  An obligatory role for nitric oxide in autonomic control of mammalian heart rate.

Authors:  X Han; Y Shimoni; W R Giles
Journal:  J Physiol       Date:  1994-04-15       Impact factor: 5.182

View more
  15 in total

1.  Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.

Authors:  J Mialet; I Berque-Bestel; P Eftekhari; M Gastineau; M Giner; Y Dahmoune; P Donzeau-Gouge; J Hoebeke; M Langlois; S Sicsic; R Fischmeister; F Lezoualc'h
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Cytochalasin D reduces Ca2+ currents via cofilin-activated depolymerization of F-actin in guinea-pig cardiomyocytes.

Authors:  U Rueckschloss; G Isenberg
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

3.  Local response of L-type Ca(2+) current to nitric oxide in frog ventricular myocytes.

Authors:  M Dittrich; J Jurevicius; M Georget; F Rochais; B Fleischmann; J Hescheler; R Fischmeister
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

4.  cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes.

Authors:  M Rivet-Bastide; G Vandecasteele; S Hatem; I Verde; A Bénardeau; J J Mercadier; R Fischmeister
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

5.  Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.

Authors:  I Verde; G Vandecasteele; F Lezoualc'h; R Fischmeister
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

6.  Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes.

Authors:  G Vandecasteele; I Verde; C Rücker-Martin; P Donzeau-Gouge; R Fischmeister
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

7.  Role of the NO-cGMP pathway in the muscarinic regulation of the L-type Ca2+ current in human atrial myocytes.

Authors:  G Vandecasteele; T Eschenhagen; R Fischmeister
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

8.  Guanosine 3': 5'-cyclic monophosphate-dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive rats.

Authors:  L Mazzetti; C Ruocco; L Giovannelli; M Ciuffi; S Franchi-Micheli; F Marra; L Zilletti; P Failli
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism.

Authors:  Tommaso Angelone; Anna Maria Quintieri; Bhawanjit K Brar; Pauline T Limchaiyawat; Bruno Tota; Sushil K Mahata; Maria Carmela Cerra
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

10.  Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotection.

Authors:  C Rocca; F Scavello; M C Granieri; T Pasqua; N Amodio; S Imbrogno; A Gattuso; R Mazza; Maria Carmela Cerra; Tommaso Angelone
Journal:  Cell Mol Life Sci       Date:  2017-09-30       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.